- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Swiss Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
2
0 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
2 companies
Novartis
Market Cap: CHF 200.4b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 104.42
7D
2.4%
1Y
13.9%
Xlife Sciences
Market Cap: CHF 100.9m
Focuses on the development and commercialization of research projects in the life sciences sector.
XLS
CHF 17.50
7D
-2.8%
1Y
-38.8%